7 reports

NO has a solid place in asthma management.

  • Drug Test
  • United States
  • Alere Inc.
  • Dräger Group
  • Thermo Fisher Scientific, Inc.

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Cardiovascular Disease
  • Clinical Trial
  • Lipid Modifying Drug
  • Statins
  • World

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Cardiovascular Disease
  • Clinical Trial
  • Lipid Modifying Drug
  • Statins
  • World

The prominent features of this report are - ##.

  • Cardiovascular Disease
  • Lipid Modifying Drug
  • Pharmaceutical
  • Statins
  • World

Part ##.

  • Clinical Trial
  • Drug Discovery And Development
  • Statins
  • World
  • Merck & Co., Inc.

Its ketas product is a phosphodiesterase inhibitor agent for ameliorating bronchial asthma and cerebro-vascular disorders.

  • Cholesterol
  • Chronic Disease
  • Pharmaceutical
  • Statins
  • Amarin Corporation plc

Its ketas product is a phosphodiesterase inhibitor agent for ameliorating bronchial asthma and cerebro-vascular disorders.

  • Chronic Disease
  • Statins
  • United States
  • World
  • Product Initiative